by admin | Mar 1, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Ty Roush – Forbes A 53-year-old man from Germany has been cured of HIV after receiving a stem cell transplant in 2014, according to findings published Monday in Nature Medicine, as researchers say he is the fifth to be cured of the virus—which affects more...
by admin | Feb 28, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by William A. Haseltine – Forbes As part of our series in cellular therapy, we previously described how CAR T therapy for treatment of B cell leukemia achieved early success in the field. T cell leukemia, however, engages a different part of the immune system...
by admin | Feb 26, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions, Video
Scientists have made a breakthrough that could make all the difference in helping treat and, one day, cure patients with neurodegenerative diseases. by Lindsey Theis – Scripps News Scientists have made a key discovery they think could be a crucial step in...
by admin | Feb 25, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
The World Stem Cell Summit returns as a live event June 5-9. Combined with the Regenerative Medicine Essentials Course- certificate and CME credits applied for. The Summit is meant to fill an unmet need in the regenerative medicine conference world, with its focus on...
by admin | Feb 24, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Ria Kakkad – Drug Target Review Researchers at the University of California, San Francisco (UCSF), US, have developed a novel, potentially life-saving approach that may prevent antibodies from triggering immune rejection of engineered therapeutic and...
by admin | Feb 23, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Cedars-Sinai Cancer Stem Cell Transplant and Cellular Therapy Program Receives Expanded Accreditation and Top Ranking for Patient Survival Rates by Christina Elston – Cedars Sinai Image: Illustration of CAR (chimeric antigen receptor) T cell immunotherapy, a...